HANMI PHARM. CO., LTD.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 50205
 
  
 
C07K PEPTIDES 19117
 
  
 
C07D HETEROCYCLIC COMPOUNDS 13149
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 491
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 346
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 2165
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 297
 
  
 
A61F FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS 1139
 
  
 
B60R VEHICLES, VEHICLE FITTINGS, OR VEHICLE PARTS, NOT OTHERWISE PROVIDED FOR 1109
 
  
 
B65B MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING 163

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0368,049 COMPOSITE CAPSULES COMPRISING RALOXIFENE, AND VITAMIN D OR ITS DERIVATIVESJan 28, 16Dec 28, 17[A61K]
2017/0226,175 INSULINOTROPIC PEPTIDE DERIVATIVE WITH MODIFIED N-TERMINAL CHARGEApr 25, 17Aug 10, 17[C07K]
2017/0128,589 METHOD FOR IMPROVING SOLUBILITY OF PROTEIN AND PEPTIDE BY USING IMMUNOGLOGULIN FC FRAGMENT LINKAGEMar 31, 15May 11, 17[A61K, C07K]
2017/0112,799 AMORPHOUS SOLID DISPERSION COMPRISING TAXANE, TABLET COMPRISING THE SAME, AND METHOD FOR PREPARING THE SAMEMar 20, 15Apr 27, 17[A61K]
2017/0100,488 METHOD FOR DECREASING IMMUNOGENICITY OF PROTEIN AND PEPTIDEJun 05, 15Apr 13, 17[A61K]
2016/0215,278 METHOD FOR MASS PRODUCTION OF FACTOR VII/VIIA DERIVATIVESAug 27, 14Jul 28, 16[C12N]
2016/0152,684 IMMUNOGLOBULIN FC CONJUGATE WHICH MAINTAINS BINDING AFFINITY OF IMMUNOGLOBULIN FC FRAGMENT TO FCRNJul 14, 14Jun 02, 16[C07K]
2016/0089,339 CAPSULE FORMULATION COMPRISING MONTELUKAST AND LEVOCETIRIZINENov 06, 15Mar 31, 16[A61K]
2016/0008,483 NOVEL INSULIN ANALOG AND USE THEREOFFeb 26, 14Jan 14, 16[A61K, C07K]
2016/0008,484 IMPROVED PREPARATION METHOD FOR HIGH-YIELD PRODUCTION OF PHYSIOLOGICALLY ACTIVE POLYPEPTIDE CONJUGATEMar 05, 14Jan 14, 16[A61K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9901621 Composition for treating hyperlipidemia comprising oxyntomodulin derivativeMar 31, 16Feb 27, 18[A61K, A61P, C07K]
9867801 Amorphous solid dispersion comprising taxane, tablet comprising the same, and method for preparing the sameMar 20, 15Jan 16, 18[A61K]
9833413 Pharmaceutical combination formulation comprising amlodipine, losartan and rosuvastatinNov 20, 14Dec 05, 17[A61K]
9833516 Liquid formulation of long-acting insulin and insulinotropic peptideJul 25, 13Dec 05, 17[A61K]
9828366 Bicyclic derivatives and pharmaceutical composition including the sameMay 08, 15Nov 28, 17[C07H, C07D]
9801876 Complex granule formulation having improved stability comprising levocetirizine and montelukastJun 16, 14Oct 31, 17[A61K]
9801950 Liquid formulation of long acting insulinotropic peptide conjugateJul 25, 13Oct 31, 17[A61K, C12P, C07K]
9731022 Pharmaceutical composition comprising amide derivative inhibiting the growth of cancer cells and non-metallic salt lubricantMay 18, 12Aug 15, 17[A61K, C07D]
9724420 Liquid formulation of protein conjugate comprising an oxyntomodulin derivative covalently linked to a non-peptidyl polymer to an immunoglobulin FC regionNov 06, 13Aug 08, 17[A61K, C07K]
9663565 Insulinotropic peptide derivative with modified N-terminal chargeJan 03, 14May 30, 17[A61K, A61P, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0157,108 LIQUID FORMULATION COMPRISING MONTELUKAST OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND METHOD FOR PREPARING SAMEAbandonedDec 17, 14Jun 08, 17[A61K]
2016/0263,040 COMPOSITE FORMULATION COMPRISING TADALAFIL AND AMLODIPINEAbandonedNov 06, 14Sep 15, 16[A61K]
2016/0045,444 COMPOSITE FORMULATION COMPRISING A FILM COATING LAYER CONTAINING ROSUVASTATIN OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOFAbandonedApr 30, 14Feb 18, 16[A61K]
2015/0299,185 NOVEL IMIDAZOPYRIDINE DERIVATIVES AS A TYROSINE KINASE INHIBITORAbandonedDec 27, 12Oct 22, 15[A61K, C07D]
2015/0231,085 PHARMACEUTICAL COMPOSITE CAPSULE FORMULATION COMPRISING IRBESARTAN AND HMG-COA REDUCTASE INHIBITORAbandonedAug 30, 13Aug 20, 15[A61K]
2015/0209,290 BILAYERED COMPOSITE TABLET FORMULATION COMPRISING ATORVASTATIN, IRBESARTAN AND MAGNESIUM CARBONATEAbandonedAug 30, 13Jul 30, 15[A61K]
2015/0182,593 COMPOSITION FOR TREATING HYPERLIPIDEMIA COMPRISING OXYNTOMODULIN DERIVATIVEAbandonedJul 25, 13Jul 02, 15[A61K, C07K]
2015/0098,992 COMPOSITE FORMULATION COMPRISING MULTI-UNIT SPHEROIDAL TABLET (MUST) ENCAPSULATED IN HARD CAPSULE AND METHOD FOR PREPARING SAMEAbandonedApr 12, 13Apr 09, 15[A61K]
2014/0364,438 TRIAZOLOPYRIDINE DERIVATIVES AS A TYROSINE KINASE INHIBITORAbandonedJan 23, 13Dec 11, 14[A61K, C07D]
2014/0314,844 ORAL COMPLEX FORMULATION COMPRISING OMEGA-3 FATTY ACID AND HMG-COA REDUCTASE INHIBITOR WITH IMPROVED STABILITYAbandonedNov 16, 12Oct 23, 14[A61K]
2014/0170,213 CAPSULE FORMULATION COMPRISING MONTELUKAST AND LEVOCETIRIZINEAbandonedJul 11, 12Jun 19, 14[A61K]
2014/0163,226 NOVEL PYRIMIDINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION INCLUDING SAME AS AN ACTIVE INGREDIENTAbandonedJun 29, 12Jun 12, 14[C07D]
2014/0010,872 ORAL COMPLEX COMPOSITION COMPRISING OMEGA-3 FATTY ACID ESTER AND HMG-COA REDUCTASE INHIBITORAbandonedMar 23, 12Jan 09, 14[A61K]
2012/0110,957 METHOD FOR PREPARING RAPIDLY DISINTEGRATING FORMULATION FOR ORAL ADMINISTRATIONAbandonedJan 05, 12May 10, 12[B65B]
7763730 Method preparation clopidogrel and intermediates used thereinExpiredAug 28, 09Jul 27, 10[C07D]
2010/0120,888 ATORVASTATIN STRONTIUM SALT AND PHARMACEUTICAL COMPOSITION COMPRISING SAMEAbandonedJan 21, 08May 13, 10[A61K, C07D, A61P]
7704526 Sustained release composition for oral administration of drugsExpiredAug 27, 03Apr 27, 10[A61K]
2010/0099,884 METHOD OF PREPARING S-(-)-AMLODIPINE OR A SALT THEREOF AND AN INTERMEDIATE USED THEREINAbandonedJan 29, 08Apr 22, 10[C07D]
2010/0003,289 Controlled Release Complex Formulation For Oral Administration of Medicine For Diabetes and Method For The Preparation ThereofAbandonedDec 28, 05Jan 07, 10[A61K, A61P]
2009/0326,234 (S)-(-)-Amlodipine Camsylate or Hydrate Thereof And Pharmaceutical Composition Comprising SameAbandonedJul 16, 07Dec 31, 09[C07D]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.